This analysis examines biopharmaceutical and pharmacotechnical properties of tablets from Atriplex halimus powder, suggesting potential in therapeutic applications.
The present study aims to develop tablets based on plant powder obtained by direct compression. In this work, the effects of two parameters (the powder particle size and the force of compression) have been studied. Powder from the aerial portion of Atriplex halimus was used as a model. The composition of the powder and its technological properties were determined. A compression process study was carried out, and the macroscopic and pharmacotechnical properties of the resulting tablets were studied. Finally, an in vitro dissolution kinetics study in the absence and presence of digestive enzymes was evaluated. Plant powders, with a particle size between 100 and 500 µm, allowed us to have excellent quality tablets after direct compression with a force of 14 KN. The obtained tablets comply with the requirements of the European Pharmacopoeia standards, they have good swelling and erosive properties, and they have shown good structure after observation with a scanning electron microscope. An in vitro dissolution kinetics study of these tablets composed of 100% plant powder showed that maximum dissolution rates are reached after 5 h of dissolution in the absence of digestive enzymes and 3 h in their presence. This result highlights the potential of plant powder administration as a valuable therapeutic strategy.
No takes yet. Share an insight, caveat, or question.
Bachir et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: